Search - tctmd.com

Displaying 41 - 60 of 264

Sort: Relevancy | Date

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

August 15, 2024

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

August 13, 2024

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

May 23, 2024

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

Atherosclerosis Progression May Share Traits With Tumor Growth

News Daily News

Atherosclerosis Progression May Share Traits With Tumor Growth

May 08, 2024

Time-Restricted Eating, High-Intensity Training Have Heart Benefits for Obese Women

News Daily News

Time-Restricted Eating, High-Intensity Training Have Heart Benefits for Obese Women

May 07, 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

April 06, 2024

High Lp(a) Levels Harmful in Patients With and Without ASCVD

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

February 02, 2024

AHA Updates Its Scientific Statement on CIED Infections

News Daily News

AHA Updates Its Scientific Statement on CIED Infections

December 11, 2023

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

November 20, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

TCTMD’s Top 10 Most Popular Stories for October 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

November 01, 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

October 25, 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

Combined Surgical and Catheter Ablation Best for Persistent AF

News Conference News EACTS 2023

Combined Surgical and Catheter Ablation Best for Persistent AF

Michael O'Riordan

October 12, 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.